ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NTHI vs TNXP // RETURN ON INVESTED CAPITAL (ROIC)

NeOnc Technologies Holdings Inc. (NASDAQ) VS. Tonix Pharmaceuticals Holding Corp. (NASDAQ) • 15-METRIC TALLY: NTHI 2 — TNXP 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NTHI VS. TNXP) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NTHI TNXP SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 49.30% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -21.93% — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -51.80% 29.80% -81.60 TNXP /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 5/9 -4.00 TNXP /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 50.6 17.4 +33.20 NTHI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $92.9M $90.6M $2.3M NTHI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NTHI REV TNXP REV NTHI GROSS % TNXP GROSS % NTHI FCF TNXP FCF
FY 2025 $40.0K $13.1M — 49.3% -$20.4M -$103.2M
FY 2024 $83.0K $10.1M — 23.1% -$4.2M -$61.0M
FY 2023 — $7.8M — — — -$102.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NTHI // BETA —
TNXP // BETA —